Langerhans cell histiocytosis in IPEX syndrome: Possible role for natural regulatory T cells?

Pediatric Allergy and Immunology

Volumn 25, Issue 6, 2014, Pages 601-603

  Sayar, Ersin ^a   Uygun, Dilara F Kocacik ^b   Islek, Ali ^c   Hazar Sayar, Esra ^d   Akkaya, Bahar ^c   Vignoli, Marina ^e   Gambineri, Eleonora ^e,f   Yesilipek, Mehmet Akif ^g   Artan, Reha ^c  

^a KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^d NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g BAHCESEHIR UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TRANSCRIPTION FACTOR FOXP3; CD1 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; PROTEIN S 100;

AXILLARY LYMPH NODE; CASE REPORT; CHEMOTHERAPY; DIARRHEA; DISEASE COURSE; ERYTHRODERMA; EXON; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DYSREGULATION; INFANT; IPEX SYNDROME; LANGERHANS CELL HISTIOCYTOSIS; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MACULOPAPULAR RASH; MALE; PRIORITY JOURNAL; RASH; REGULATORY T LYMPHOCYTE; SEQUENCE ANALYSIS; COMPLICATION; GENETICS; HISTIOCYTOSIS, LANGERHANS-CELL; IMMUNOLOGY; LANGERHANS CELL; LYMPHOPROLIFERATIVE DISORDERS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ANTIGENS, CD1; DIARRHEA; DNA MUTATIONAL ANALYSIS; EXANTHEMA; FORKHEAD TRANSCRIPTION FACTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; LANGERHANS CELLS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MUTATION; S100 PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 84922954100     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12219     Document Type: Letter

References (13)

1. Abla O, Egeler RM, Weitzman S. Langerhans cell histiocytosis. Current concepts and treatment. Cancer Treat Rev 2010: 36: 354-9.
2. Donadieu J, Chalard F, Jeziorski E. Medical management of langerhans cell histiocytosis from diagnosis to treatment. Expert Opin Pharmacother 2012: 13: 1309-22.
3. Purtilo DT, Cassel JK, Yang JP, Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975: 26: 935-40.
4. Zhang X, Zhu D, Lan H, et al. Langerhans cell histiocytosis, a new clinical phenotype of X-linked lymphoproliferative disease? Eur J Med Genet 2011: 54: 165-8.
5. Tsuda M, Torgerson TR, Selmi C, et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 2010: 35: 265-8.
6. Allen CE, Li L, Peters TL, et al. Cell-spesific gene expression in langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal langerhans cells. J Immunol 2010: 184: 4557-67.
7. Senechal B, Elain G, Jeziorski E, et al. Expansion of regulatory T cells in patients with langerhans cell histiocytosis. PLoS Med 2007: 4: e253.
8. Barzaghi F, Passerini L, Bachetta R. Immundysregulation, poliendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immundeficiency with autoimmunity. Front Immunol 2012: 3: 1-25.
9. Katoh H, Zheng P, Liu Y. FOXP3: genetic and epigenetic implications for autoimmunity. J Autoimmun 2013: 41: 72-8.
10. Kinnunen T, Chamberlain N, Morbach H, et al. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood 2013: 121: 1595-603.
11. Menard L, Cantaert T, Chamberlein N, et al. Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance. J Allergy Clin Immunol 2013. doi: 10.1016/j.jaci.2013.10.051. [Epub ahead of print].
12. Consolini R, Cini P, Cei B, Bottone E. Thymic dysfunction in Histiocytosis-X. Am J Pediatr Hematol Oncol 1987: 9: 146-8.
13. Hait E, Liang M, Degar B, Glickman J, Fox VL. Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. Pediatrics 2006: 118: e1593-9.